We came across a bullish thesis on Bristol-Myers Squibb Company on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company's share was trading at $49 recently. BMY’s trailing and forward P/E were 16.6 and 8 respectively according to Yahoo Finance. 10 Pharmacist Shortage Countries in Need of Pharmacists in 2017 Iakov Filimonov/Shutterstock.com Bristol-Myers Squibb Co. (NYSE: BMY) appears modestly undervalued following its recent earnings releas ...